Sponsors

Disease map

French genomics company IntegraGen has discovered a groundbreaking method of identifying causal disease genes, with the aid of Applied BiosystemsÆ custom assays and the SNPIex genotyping system.

Its gene-mapping technology û genome hybrid identity profiling (GenomeHIP) û works on the assumption that the same disease genes will be found in related individuals with the same disease, so the disease loci can be mapped by removing non-identical DNA sequences the genomes share. J÷rg Hager, IntegraGenÆs chief scientific officer, explained how Applied BiosystemsÆ products have helped: ôFor any disease in a given population, we identify up to seven potential disease loci, assemble a panel of region-specific SNPs and have assays manufactured by Applied Biosystems. Within a couple of days we can use the assays to analyse a large number of individuals using the SNPIex Genotyping System.ö

Latest Issues

ECP 2026 - 38th European Congress of Pathology

Stockholmsmässan, Stockholm, Sweden
12-16 September, 2026

UK NEQAS Parasitology Symposium

UKHSA, 61 Colindale Avenue, London NW9 5EQ
18 September, 2026

UKHSA Conference 2026

Manchester Central, Manchester, M2 3GX
22-23 September, 2026

Cardiac Marker Dialogues

Technology and Innovation Centre, University of Strathclyde, 99 George Street, Glasgow, G1 1RD
24-25 September, 2026

46th European Congress of Cytology

Hilton Antwerp Old Town, Antwerp
4-7 October, 2026